Lungs and Scleroderma (2026)

Pulmonary complications are among the most serious in scleroderma. In this session, Toby Maher, MD (Keck School of Medicine of the University of Southern California) offers an in-depth exploration of how scleroderma affects the lungs, covering the most common pulmonary complications, how they’re monitored and treated, and what patients can do to protect and support their respiratory health.

This session was originally presented on June 11, 2026, as part of the 5th annual SRF Scleroderma Patient Forum.